rs121434422

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong

The NM_001492.6(GDF1):​c.681C>A​(p.Cys227*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000943 in 1,073,414 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.00054 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0010 ( 0 hom. )

Consequence

GDF1
NM_001492.6 stop_gained

Scores

1
1
4

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:16

Conservation

PhyloP100: -0.0420

Publications

7 publications found
Variant links:
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]
CERS1 Gene-Disease associations (from GenCC):
  • progressive myoclonic epilepsy type 8
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 16 pathogenic variants in the truncated region.
PP5
Variant 19-18869035-G-T is Pathogenic according to our data. Variant chr19-18869035-G-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 6747.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001492.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF1
NM_001492.6
MANE Select
c.681C>Ap.Cys227*
stop_gained
Exon 8 of 8NP_001483.3
CERS1
NM_021267.5
MANE Select
c.*950C>A
3_prime_UTR
Exon 8 of 8NP_067090.1P27544-1
GDF1
NM_001387438.1
c.681C>Ap.Cys227*
stop_gained
Exon 5 of 5NP_001374367.1P27539

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GDF1
ENST00000247005.8
TSL:1 MANE Select
c.681C>Ap.Cys227*
stop_gained
Exon 8 of 8ENSP00000247005.5P27539
CERS1
ENST00000623882.4
TSL:1 MANE Select
c.*950C>A
3_prime_UTR
Exon 8 of 8ENSP00000485308.1P27544-1

Frequencies

GnomAD3 genomes
AF:
0.000536
AC:
79
AN:
147314
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000146
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000918
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000967
Gnomad OTH
AF:
0.000492
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
306
AF XY:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00101
AC:
933
AN:
926100
Hom.:
0
Cov.:
29
AF XY:
0.000995
AC XY:
433
AN XY:
435070
show subpopulations
African (AFR)
AF:
0.000172
AC:
3
AN:
17472
American (AMR)
AF:
0.00
AC:
0
AN:
3626
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
7656
East Asian (EAS)
AF:
0.00
AC:
0
AN:
10490
South Asian (SAS)
AF:
0.00
AC:
0
AN:
18334
European-Finnish (FIN)
AF:
0.00173
AC:
21
AN:
12150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2080
European-Non Finnish (NFE)
AF:
0.00108
AC:
887
AN:
821586
Other (OTH)
AF:
0.000673
AC:
22
AN:
32706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000536
AC:
79
AN:
147314
Hom.:
0
Cov.:
33
AF XY:
0.000544
AC XY:
39
AN XY:
71724
show subpopulations
African (AFR)
AF:
0.000146
AC:
6
AN:
40986
American (AMR)
AF:
0.00
AC:
0
AN:
14830
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3390
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5150
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000918
AC:
8
AN:
8712
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
312
European-Non Finnish (NFE)
AF:
0.000967
AC:
64
AN:
66158
Other (OTH)
AF:
0.000492
AC:
1
AN:
2032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
6
11
17
22
28
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00115
Hom.:
0
Bravo
AF:
0.000465

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
5
-
-
Right atrial isomerism (5)
4
-
-
not provided (4)
3
-
-
Congenital heart defects, multiple types, 6;C3178806:Right atrial isomerism (3)
1
-
-
Congenital heart defects, multiple types, 6 (1)
1
-
-
GDF1-related disorder (1)
1
-
-
GDF1-RELATED DISORDERS (1)
1
-
-
Transposition of the great arteries (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Uncertain
0.11
CADD
Pathogenic
32
DANN
Benign
0.96
Eigen
Benign
-0.67
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.024
N
PhyloP100
-0.042
Vest4
0.57
GERP RS
-2.4
Mutation Taster
=51/149
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121434422; hg19: chr19-18979844; API